Eric joined MVM in 2008 from Advent International in Boston where he was involved in several healthcare investments. Prior to that, Eric was a Director in the Corporate Finance Group of Silicon Valley Bank. Eric previously worked in the drug discovery group of Dupont-Merck Pharmaceuticals. He has a B.S. degree from Brown University and a Ph.D. in Neurobiology from the University of California.
Eric oversees MVM's investment in Aegerion Pharmaceuticals, Inc. and is a member of the board of Tarsa Therapeutics, Inc.
